SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
1320634
Source:
http://linkedlifedata.com/resource/pubmed/id/1320634
Search
Subject
(
71
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003241
,
umls-concept:C0079941
,
umls-concept:C0229671
,
umls-concept:C0279672
,
umls-concept:C0597551
,
umls-concept:C0999807
pubmed:issue
6
pubmed:dateCreated
1992-8-13
pubmed:abstractText
To determine if there are type specific differences in serum antibody responses to synthetic peptides derived from human papillomavirus (HPV) open reading frame (ORF) E2 in patients with cervical carcinoma.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-1649138
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-1698732
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-1846186
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-1850951
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-1851501
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-2174733
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-2471193
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-2547317
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-2547512
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-2553963
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-2826817
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-2831924
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-2990099
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-3008427
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-3039146
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-6259398
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1320634-6321162
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0376601
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin A
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0021-9746
pubmed:author
pubmed-author:DillnerJJ
,
pubmed-author:HyötyHH
,
pubmed-author:LehtinenMM
,
pubmed-author:LehtovirtaPP
,
pubmed-author:LeminenAA
,
pubmed-author:PaavonenJJ
,
pubmed-author:VesterinenEE
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
494-7
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed-meshheading:1320634-Adenocarcinoma
,
pubmed-meshheading:1320634-Adult
,
pubmed-meshheading:1320634-Aged
,
pubmed-meshheading:1320634-Aged, 80 and over
,
pubmed-meshheading:1320634-Antibodies, Viral
,
pubmed-meshheading:1320634-Antigenic Variation
,
pubmed-meshheading:1320634-Carcinoma, Squamous Cell
,
pubmed-meshheading:1320634-Female
,
pubmed-meshheading:1320634-Humans
,
pubmed-meshheading:1320634-Immunoglobulin A
,
pubmed-meshheading:1320634-Immunoglobulin G
,
pubmed-meshheading:1320634-Middle Aged
,
pubmed-meshheading:1320634-Open Reading Frames
,
pubmed-meshheading:1320634-Papillomaviridae
,
pubmed-meshheading:1320634-Peptide Fragments
,
pubmed-meshheading:1320634-Tumor Virus Infections
,
pubmed-meshheading:1320634-Uterine Cervical Neoplasms
pubmed:year
1992
pubmed:articleTitle
Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma.
pubmed:affiliation
Institute of Biomedical Sciences, University of Tampere, Finland.
pubmed:publicationType
Journal Article